Zealand Pharma A/S
CSE:ZEAL
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
310.8
783.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
ZEAL
stock under the Base Case scenario is
hidden
DKK.
Compared to the current market price of 407.3 DKK,
Zealand Pharma A/S
is
hidden
.
Valuation History
Zealand Pharma A/S
ZEAL looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if ZEAL is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Zealand Pharma A/S.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Zealand Pharma A/S
Balance Sheet Decomposition
Zealand Pharma A/S
Zealand Pharma A/S
Free Cash Flow Analysis
Zealand Pharma A/S
| DKK | |
| Free Cash Flow | DKK |
Earnings Waterfall
Zealand Pharma A/S
ZEAL Profitability Score
Profitability Due Diligence
Score
ZEAL Solvency Score
Solvency Due Diligence
Score
Wall St
Price Targets
ZEAL Price Targets Summary
Zealand Pharma A/S
According to Wall Street analysts, the average 1-year price target for
ZEAL
is 719.24 DKK
with a low forecast of 404 DKK and a high forecast of 1 176 DKK.
Dividends
Current shareholder yield for
ZEAL is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ZEAL
stock under the Base Case scenario is
hidden
DKK.
Compared to the current market price of 407.3 DKK,
Zealand Pharma A/S
is
hidden
.